All In Biotech

Free tool

FAERS Monitor: Fiasp Penfill

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 208751 or its brand name (Fiasp Penfill, Insulin Aspart). Reports on generic versions are filed under their own applications.

Reports

12,548

Serious

10,461

83% of reports

Hospitalization

6,133

Death reported

1,455

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased1,093
  • nausea814
  • dyspnoea754
  • hypoglycaemia743
  • vomiting717
  • off label use711
  • drug ineffective643
  • abdominal pain542
  • diarrhoea525
  • condition aggravated522
  • fatigue516
  • acute kidney injury466
  • general physical health deterioration430
  • hyperglycaemia427
  • sepsis419

Reports by year received

View as table
YearReports
200435
200530
200635
200765
2008110
2009137
2010111
201197
2012146
2013193
2014238
2015311
2016353
2017384
2018711
2019769
2020893
20211,227
20221,291
20231,222
20241,406
20251,610
20261,174

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,611 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypoglycaemiaSignal74326.124.317,648
hyperglycaemiaSignal42719.918.17,554
blood glucose increasedSignal1,0939.89.28,628
sepsisSignal4196.35.71,873
general physical health deteriorationSignal4306.25.71,894
acute kidney injurySignal4665.14.71,546
abdominal painSignal5423.93.61,182
condition aggravatedSignal5222.92.6647
vomitingSignal7172.62.4694
dyspnoeaSignal7542.22.1526
nausea8141.71.6257
diarrhoea5251.41.352
off label use7111.41.371
fatigue5161.11.06
drug ineffective6430.80.828

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.